The role of Mcl-1 in the macrophages and RA
The role of Mcl-1 in the macrophages and RA
批准号:
6836040
负责人:
Richard M. Pope
金额:
$27.55万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-01 至 2007-12-31
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. Monocytes/macrophages are vital for host-immune responses and have been implicated in the pathogenesis of rheumatoid arthritis (RA). We demonstrated that PI3K/Akt-l-dependent Mcl-1 expression is vital for macrophage survival. Suppression of PI3K/Akt reduced Mcl-1 expression, resulting in apoptosis mediated through the mitochondrial pathway. Forced downregulation of Mcl-1 through antisense oligonucleotides also induced apoptosis, demonstrating that Mcl-1 is essential for macrophage viability. Further, our preliminary data suggested that Mcl-1 may also be regulated by the JAK/STAT pathway in human macrophages. Therefore, we propose to determine the mechanisms by which the PI3K/Akt and JAK/STAT3 pathways contribute to the regulation of Mcl-1 in macrophages. Additionally, we will identify the mechanism by which Mcl-1 protects macrophages by examining the interaction of Mcl-1 with pro-apoptotic molecules, such as Bax in macrophages to delineate the mechanism of mitochondrial dysfunction that occurs following Mcl-1 ablation. Our preliminary data suggests that Mcl-1 may be important in the in maintaining the viability of RA synovial macrophages. Additionally, our preliminary data has revealed that in vitro, Mcl-1 was highly expressed in RA, compared to osteoarthritis (OA), synovial fibroblasts. Mcl-1 was also strongly expressed in the synovium of rats with adjuvant-induced arthritis (AIA). Therefore, we propose to characterize the expression and function of Mcl-1 in the RA joint, examining macrophages and synovial fibroblasts. We propose to determine if the forced downregulation of Mcl-1 will ameliorate experimental arthritis, which would indicate that Mcl-1 is a contributor to the initiation and/or progression of arthritis. Thus, this proposal will delineate the mechanisms regulating the expression and the novel functions of Mcl-1 in macrophages. Further studies are proposed to delineate potential cell type-specific differences between macrophages and normal, osteoarthritis and rheumatoid arthritis synovial fibroblasts. These experiments will provide new and important information concerning the novel role of Mcl-1, which may provide insights that will lead to the development of improved therapy for patients with RA. PERFORMANCESITE( ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inflammatory Arthritis: Mechanistic Insights into Initiation and Progression
-
批准号:10171786
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2017
-
负责人:Richard M. Pope
-
依托单位:
Role of CCR7 in Clinical Response in Inflammatory Arthritis
-
批准号:8575034
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2013
-
负责人:Richard M. Pope
-
依托单位:
Role of CCR7 in Clinical Response in Inflammatory Arthritis
-
批准号:8689914
-
项目类别:
-
资助金额:$16.42万
-
财政年份:2013
-
负责人:Richard M. Pope
-
依托单位:
Role of Stress-Response Protein gp96 in the Persistence of Rheumatoid Arthritis
-
批准号:8130956
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2008
-
负责人:Richard M. Pope
-
依托单位:
Role of Stress-Response Protein gp96 in the Persistence of Rheumatoid Arthritis
-
批准号:7583151
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2008
-
负责人:Richard M. Pope
-
依托单位:
Role of Stress-Response Protein gp96 in the Persistence of Rheumatoid Arthritis
-
批准号:7906026
-
项目类别:
-
资助金额:$34.36万
-
财政年份:2008
-
负责人:Richard M. Pope
-
依托单位:
Role of Stress-Response Protein gp96 in the Persistence of Rheumatoid Arthritis
-
批准号:7690772
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2008
-
负责人:Richard M. Pope
-
依托单位:
Role of Stress-Response Protein gp96 in the Persistence of Rheumatoid Arthritis
-
批准号:8311563
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2008
-
负责人:Richard M. Pope
-
依托单位:
Administrative Core
-
批准号:7267286
-
项目类别:
-
资助金额:$12.51万
-
财政年份:2007
-
负责人:Richard M. Pope
-
依托单位:
Role of Flip Macrophages
-
批准号:6630208
-
项目类别:
-
资助金额:$27.67万
-
财政年份:2003
-
负责人:Richard M. Pope
-
依托单位:
The role of Mcl-1 in the macrophages and RA
-
批准号:6558192
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2003
-
负责人:Richard M. Pope
-
依托单位:
The role of Mcl-1 in the macrophages and RA
-
批准号:6694428
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2003
-
负责人:Richard M. Pope
-
依托单位:
Role of Flip Macrophages
-
批准号:7256259
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2003
-
负责人:Richard M. Pope
-
依托单位:
Role of Flip Macrophages
-
批准号:6915216
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2003
-
负责人:Richard M. Pope
-
依托单位:
Role of Flip Macrophages
-
批准号:6760228
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2003
-
负责人:Richard M. Pope
-
依托单位:
The role of Mcl-1 in the macrophages and RA
-
批准号:6990591
-
项目类别:
-
资助金额:$25.09万
-
财政年份:2003
-
负责人:Richard M. Pope
-
依托单位:
The role of Mcl-1 in the macrophages and RA
-
批准号:7178553
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2003
-
负责人:Richard M. Pope
-
依托单位:
Role of Flip Macrophages
-
批准号:7103409
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2003
-
负责人:Richard M. Pope
-
依托单位:
Multidisciplinary Clinical Research Center in Rheumatology
-
批准号:7906737
-
项目类别:
-
资助金额:$117.14万
-
财政年份:2002
-
负责人:Richard M. Pope
-
依托单位:
Multidisciplinary Clinical Research Center in Rheumatology
-
批准号:7665025
-
项目类别:
-
资助金额:$116.58万
-
财政年份:2002
-
负责人:Richard M. Pope
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RanBP2促进MCL1蛋白SUMO化调控食管鳞
癌放免治疗抵抗的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:100.0万元
-
批准年份:2025
-
负责人:习勉
-
依托单位:
孕期重金属混合暴露对胎儿生长受限的影响及MCL-1降解介导的胎盘凋亡在其中的调控作用研究
-
批准号:2025JJ60756
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈欢
-
依托单位:
USP15 稳定Mcl-1促进口腔癌放疗抵抗
-
批准号:2024JJ9519
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:周中苏
-
依托单位:
CDK4-GCN5增强MCL1琥珀酰化修饰促进浆液性卵巢癌进展和顺铂耐药的机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:皮亚男
-
依托单位:
基于“肠-肝 ”胆汁酸代谢轴动态调控 PU.1/MCL1 靶
向肝癌耐药的机制研究
-
批准号:2024JJ5604
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:廖明媚
-
依托单位:
CDK4-GCNS增强MCL1琥珀酰化修饰促进浆液性卵巢癌进展和顺铂耐药的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:皮亚男
-
依托单位:
Hymeglusin 调控核糖体/ERS/MCL-1 克服 AML 对 venetoclax
耐药的机制研究
-
批准号:2024JJ9278
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘灿
-
依托单位:
Mcl-1依赖凋亡通路在寨卡病毒跨越血脑屏障中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:潘攀
-
依托单位:
MCL-1液-液相分离颗粒通过抑制NHE1活性调节急性髓系白血病细胞pH稳态和耐药
-
批准号:82300187
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李明颖
-
依托单位:
碘难治性甲状腺癌中HIF-1α/Mcl-1信号介导BRAFV600E抑制剂治疗抵抗的机制研究及干预策略
-
批准号:82373315
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:渠宁
-
依托单位: